AMGN vs CAPL · P/E 24, rev $10.05B vs P/E 15, rev $2.02B
Amgen Inc (AMGN) versus Crossamerica Partners LP (CAPL) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Crossamerica Partners LP (CAPL) is a oil & gas refining & marketing company listed on NYSE.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CAPL revenue for 2026-06-30 was $2.02B. Net income was $31.5M. CAPL currently screens at market cap $818.8M and trailing P/E 14.5.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CAPL currently screens at market cap $818.8M and trailing P/E 14.5.
Not investment advice. Open the AMGN and CAPL stock pages for the full models.
Not investment advice.